NCT06957483

Brief Summary

Individuals with spinal cord injury have a greater risk of heart disease and stroke than non-disabled individuals. This might be partly because wheelchair users engage in high amounts of sedentary behaviour. A review found a lack of programmes aimed at reducing sedentary behaviour in individuals with paraplegia. This means we do not know how good these programmes are for reducing heart disease risk markers. A programme to support reductions in sedentary behaviour has been co-designed with individuals with paraplegia, healthcare professionals, and people who support individuals with paraplegia in the community. This study aims to evaluate the new programme to determine its acceptability, fidelity, safety and preliminary efficacy. The Reducing sedEntary Activities to improve Cardiovascular Health in individuals with Spinal Cord Injury (REACH -SCI) intervention will last eight weeks and involve (1) a wearable activity tracker to give reminders to break up sedentary behaviour, (2) education around what sedentary behaviour is, how to reduce and break up sedentary behaviour, and the benefits of doing so, (3) a goal setting worksheet related to sedentary behaviour, (4) one-to-one motivational support sessions to help set goals, review progress and give motivation, (5) peer support using a group chat with other participants in a smartphone messaging app , and (6) activity tools (exercise bands and a handcycle) to support breaking up sedentary behaviour throughout the day. Measurements of fatigue, pain, physical activity, sedentary behaviour, heart disease risk markers, wellbeing, anxiety, depression and quality of life will be taken at baseline before the programme starts and then again after the programme ends. Acceptability of the intervention and data collection procedures will be explored using semi-structured interviews and questionnaires.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 23, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 4, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

8 months

First QC Date

April 23, 2025

Last Update Submit

September 17, 2025

Conditions

Keywords

Cardiovascular diseaseInterventionParaplegiaPhysical activitySedentary behaviourSpinal cord injury

Outcome Measures

Primary Outcomes (5)

  • Intervention acceptability

    Following completion of the intervention, acceptability will be assessed via an adapted questionnaire with 5-point Likert scales and individual semi-structured interviews to explore constructs from the Theoretical Framework of Acceptability (TFA). The TFA assesses acceptability in the context of seven components (affective attitude, burden, ethicality, intervention coherence, opportunity costs, perceived effectiveness, and self-efficacy), as well as overall intervention acceptability.

    At intervention end (8 weeks)

  • Intervention fidelity

    Intervention fidelity will be assessed using a checklist to record each component being delivered as planned. This will include participants being provided with the wearable activity tracker, educational booklet, goal setting worksheet, exercise bands and portable hand cycle. Fidelity to the educational resource will be evaluated verbally in one-to-one motivational support sessions. Attendance at each motivational support session and duration of these sessions will be recorded. This will be in addition to a checklist for all planned aspects of the sessions being covered by the researcher delivering the intervention sessions.

    From baseline to intervention end (8 weeks)

  • Intervention safety - Adverse events

    Safety of the intervention will be evaluated through adverse events (AE) experienced during the study. These will be self-reported at each data collection point, during contact with a facilitator as part of the intervention, and ad-hoc throughout the study by contacting a member of the research team via phone or email.

    From baseline to intervention end (8 weeks)

  • Intervention safety - Pain

    Safety will also be evaluated by measuring pain using the McGill Pain Questionnaire (MPQ), which is validated in individuals with SCI. Pain will be rated across 20 domains of pain using rating scales. Overall pain will be scored from 0 to 78, with a higher score representing worse levels of pain.

    Baseline and at intervention end (8 weeks)

  • Intervention safety - Fatigue

    Safety will also be evaluated by measuring fatigue using the Modified Fatigue Impact Scale (MFIS), which is validated in individuals with SCI. Fatigue will be rated on a 5-point scale according to 21 domains of fatigue. Overall fatigue will be scored between 0 and 84, with a higher score representing worse levels of fatigue.

    Baseline and at intervention end (8 weeks)

Secondary Outcomes (22)

  • Participant engagement

    At intervention end (8 weeks)

  • Acceptability of data collection procedures

    At intervention end (8 weeks)

  • Study feasibility

    From recruitment to measurements taken at intervention end (8 weeks)

  • Sedentary time

    Baseline and in the final week of the intervention period

  • Physical activity

    Baseline and in the final week of the intervention period

  • +17 more secondary outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

All participants will receive the REACH-SCI intervention in this single-arm study. The single arm will involve a wearable activity tracker, educational resources, goal setting, motivational support from a trained researcher, peer support and activity tools. The intervention period will be for eight weeks and will start after completion of all baseline measurements and provision of all intervention materials.

Behavioral: REACH-SCI (Reducing sedEntary Activities to improve Cardiovascular Health in individuals with a Spinal Cord Injury)

Interventions

The REACH-SCI intervention was co-designed with key stakeholders and aims to reduce and break up sedentary behaviour in individuals with paraplegia. The intervention will last eight weeks and involve (1) a wearable activity tracker to give reminders to break up sedentary behaviour, (2) education around what sedentary behaviour is, how to reduce and break up sedentary behaviour, and the benefits of doing so, (3) a goal setting worksheet related to sedentary behaviour, (4) one-to-one motivational support sessions to help set goals, review progress and give motivation, (5) peer support using a smartphone app, and (6) activity tools to support breaking up sedentary behaviour throughout the day.

Also known as: REACH-SCI
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with self-reported paraplegia i.e. complete or incomplete SCI at T1 or below. Traumatic, non-traumatic, complete and incomplete SCI will all be eligible.
  • At least 18 years of age.
  • Self-report using a manual wheelchair as their primary mode of mobility inside and outside of the home.
  • Able to travel to Brunel University of London to undertake study measurements.
  • Access to use of a smartphone or tablet with internet access.
  • Able to communicate in English at a level sufficient to understand the study, complete study measurements and engage fully with the intervention.
  • Able to provide informed consent.
  • Willing and able to provide fingertip blood samples and fast prior to measurement sessions.
  • Able to independently transfer to a treatment couch and lay supine to undertake anthropometric measurements.

You may not qualify if:

  • Self-reported heart condition, chest pain, dizziness, bone or joint problem, or any other condition that may be exacerbated by doing physical activity, as indicated via responses to the PAR-Q+.
  • Self-reported history of uncontrolled autonomic dysreflexia in the past 12 months.
  • Self-reported pregnancy.
  • Currently participating in another research project that involves an intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brunel University of London

Uxbridge, London, UB8 3PH, United Kingdom

Location

MeSH Terms

Conditions

Spinal Cord InjuriesCardiovascular DiseasesParaplegiaMotor Activity

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Daniel Bailey, PhD

    Brunel University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Reader in Sedentary Behaviour and Health

Study Record Dates

First Submitted

April 23, 2025

First Posted

May 4, 2025

Study Start

May 12, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

September 22, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Raw, anonymised data will also be made publicly available in an open research repository to ensure transparency and reproducibility, but only including data from participants who consent to this. All data will be saved on a password-protected laptop and University server.

Shared Documents
STUDY PROTOCOL
Time Frame
Shared data will be available at study end following data analysis, after which there will be no time limit to gain access.
Access Criteria
Shared, anonymised data will be publicly available in an online open research repository.

Locations